Learn More
Medchemexpress LLC 1-[(3,5-dichlorophenyl)sulfonyl]-N-[(4-fluorophenyl)methyl]-4-piperidinecarboxamide | 2227549-00-8 | >95.0% | 445.34 g·mol^-1 | C19H19Cl2FN2O3S | 100MG

Supplier: Medchemexpress LLC HY124738100MG
BI-01383298 is a small-molecule chemical probe that selectively inhibits the sodium-coupled citrate transporter SLC13A5 (NaCT). Developed by Boehringer Ingelheim and distributed by research suppliers, it is used in cellular studies to probe NaCT function. The compound is provided for laboratory research use only and is characterized by a defined molecular formula and molecular weight.
- Potent inhibitor of SLC13A5 with reported cellular IC50 values in the low nanomolar range (examples: 56 nM and 24 nM).
- High selectivity over related transporters, reported greater than 1,000-fold in some assays.
- Molecular weight approximately 445.3 g·mol^-1 and formula C19H19Cl2FN2O3S.
- Typical supplier-reported purity ≥95%, with some distributors listing higher specifications.
- Available as solid quantities and as a 10 mM solution in DMSO for cell-based assays.
- For research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.